07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
JLL Partners has announced it has acquired MedeAnalytics. MedeAnalytics, based in Richardson, Texas...
Read More >
This week, the World Health Organization upgraded the global risk of the new coronavirus (COVID-19) ...
Read More >
The 10th amendment to the German Act against Restraints of Competition (ARC) entered into force on J...
Read More >
As of Dec. 21, 2019, the U.S. Trademark Office will require that owners of applications and registra...
Read More >
In 2018, this author blogged about how religious entities can navigate the potential traps when they...
Read More >
Since late December 2019, a series of earthquakes and aftershocks have struck the southwest region o...
Read More >